The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Amiodarone Has Intrinsic Anti-Trypanosoma cruzi Activity and Acts Synergistically with Posaconazole
Open accessAbstract
There is no effective treatment for the prevalent chronic form of Chagas' disease in Latin America. Its causative agent, the protozoan parasite Trypanosoma cruzi, has an essential requirement for ergosterol, and ergosterol biosynthesis inhibitors, such as the antifungal drug posaconazole, have potent trypanocidal activity. The antiarrhythmic compound amiodarone, frequently prescribed for the symptomatic treatment of Chagas' disease patients, has also recently been shown to have antifungal activity. We now show here for the first time that amiodarone has direct activity against T. cruzi, both in vitro and in vivo, and that it acts synergistically with posaconazole. We found that amiodarone, in addition to disrupting the parasites' Ca(2+) homeostasis, also blocks ergosterol biosynthesis, and that posaconazole also affects Ca(2+) homeostasis. These results provide logical explanations for the synergistic activity of amiodarone with azoles against T. cruzi and open up the possibility of novel, combination therapy approaches to the treatment of Chagas' disease using currently approved drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological Analysis of Sterol Δ8-Δ7 Isomerase Proteins with [3H]Ifenprodil
Moebius, F. F., Reiter, R. J., Bermoser, K., Glossmann, H., Cho, S. Y., & Paik, Y.-K. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.3.591 · Cited by 81
Cited by
Recent Researches in Triazole Compounds as Medicinal Drugs
-H. Zhou, C., & Wang, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803414213 · Cited by 636
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Urbina, J. A. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.10.023 · Cited by 473
Self-citationTalevi, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00205 · Cited by 381
Diagnosis and management of Chagas disease and cardiomyopathy
Ribeiro, A. L., Nunes, M. P., Teixeira, M. M., & Rocha, M. O. C. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.109 · Cited by 329
Experimental and Clinical Treatment of Chagas Disease: A Review
Sales Junior, P. A., Molina, I., Fonseca Murta, S. M., Sánchez-Montalvá, A., Salvador, F., Corrêa-Oliveira, R., & Carneiro, C. M. (2017) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0761 · Cited by 305
Requirement for Ergosterol in V-ATPase Function Underlies Antifungal Activity of Azole Drugs
Zhang, Y.-Q., Gamarra, S., Garcia-Effron, G., Park, S., Perlin, D. S., & Rao, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000939 · Cited by 206
Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans
Gamarra, S., Rocha, E. M. F., Zhang, Y.-Q., Park, S., Rao, R., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01728-09 · Cited by 70
Metadata
- Authors
- Benaim, G., Sanders, J. M., Garcia-Marchán, Y., Colina, C., Lira, R., Caldera, A. R., Payares, G., Sanoja, C., Burgos, J. M., Leon-Rossell, A., Concepcion, J. L., Schijman, A. G., Levin, M., Oldfield, E., & Urbina, J. A.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-01-05
- Volume
- 49
- Issue
- 3
- Pages
- 892-899
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2147705199
- Cited by
- 185
- References
- 1
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.